Synthesis, NMR studies and conformational analysis of oxazolidine derivatives of the β-adrenoreceptor antagonists metoprolol, atenolol and timolol

Abstract

Formaldehyde-derived oxazolidine derivatives 4–7 of the β-adrenoreceptor antagonists metoprolol 1, atenolol 2 and timolol 3 have been synthesised. Conformational analysis of 1–3 and the oxazolidine derivatives 4–7 has been performed using ¹H NMR spectroscopy and computational methods. The ¹H NMR studies show that for the aryloxypropanolamine β-adrenoreceptor antagonists there is a predominance of the conformer in which the amine group is approximately antiperiplanar or trans to the aryloxymethylene group. Both ¹H NMR data and theoretical studies indicate that the oxazolidine derivatives 4–7 and the aryloxypropanolamine β-adrenoreceptor antagonists 1–3 adopt similar conformations around the β-amino alcohol moiety. Thus, oxazolidine ring formation does not dramatically alter the preferred conformation adopted by the β-amino alcohol moiety of 1–3. Oxazolidine derivatives of aryloxypropanolamine β-adrenoreceptor antagonists may therefore be appropriate as prodrugs, or semi-rigid analogues, when greater lipophilicity is required for drug delivery.

References

1. M. A. Barrett, in Beta-adrenoceptive agonists; in Recent Advances in Cardiology, ed. Churchill Livingstone, Edinburgh, London, 1973, p. 289.
2. B. N. C. Pritchard, Am. Heart J., 1970, 79, 128.
3. B. N. C. Pritchard and P. M. S. Gillam, Brit. Med. J., 1969, 1, 7.
4. B. N. C. Pritchard, in Cardiovascular Drugs Vol. 2, β-Adrenoceptor blocking drugs, ed. G. S. Avery, ADIS Press, Seaforth, Australia, 1977, p. 85.
5. D. E. Jewitt and B. N. Singh, Prog. Cardiovasc. Dis., 1973, 16, 421.
6. B. N. Singh and D. E. Jewitt, Drugs, 1974, 7, 426.
7. J. Hamer and E. Sowton, Am. J. Cardiol., 1966, 18, 354.
8. H. Bundgaard, A. Buur, S. C. Chang and V. H. L. Lee, Int. J. Pharm., 1988, 46, 77.
9. H. Bundgaard, A. Buur, S. C. Chang and V. H. L. Lee, Int. J. Pharm., 1986, 33, 15.
10. S. J. Sorensen and S. R. Abel, The Annals of Pharmacotherapy, 1996, 30, 43.
11. Australian Pharmaceutical Formulary and Handbook, 13th edn., ed. R. A. Anderson, Griffin Press Ltd., Netley, South Australia, 1983, p. 371.
12. J. Alexander, R. Cargill, S. R. Michelson and H. Schwam, J. Med. Chem., 1988, 31, 318.
13. W. P. Munroe, J. P. Rindone and R. M. Kershner, Drug Intell. Clin. Pharm., 1985, 19, 85.
14. G. Alvan, B. Calissendorff, P. Seideman, K. Widmark and G. Widmark, Clin. Pharmacokin., 1980, 5, 95.
15. C. J. Schmitt, V. J. Lotti and J. C. Le Douarec, Arch. Opthamol., 1980, 98, 547.
16. V. J. Stella and K. J. Himmelstein, J. Med. Chem., 1980, 23, 1275.
17. N. Bordor and G. Visor, Exp. Eye. Res., 1984, 38, 621.
18. D. A. McClure, in Prodrugs as novel drug delivery systems, American Chemical Society, Washington, DC, 1975, p. 224.
19. A. Hussain and J. E. Truelove, J. Pharm. Sci., 1976, 65, 1510.
20. R. J. Lee, D. B. Evans and H. B. Sherrin, Eur. J. Pharmacol., 1975, 33, 371.
21. E. Duzman, C. C. Chen, J. Anderson, M. Blumenthal and H. Twizer, Arch. Opthalmol., 1982, 100, 1916.
22. L. Z. Bito, Exp. Eye. Res., 1984, 38, 181.
23. H. Bundgaard, E. Falch, C. Larsen, G. C. Mosher and T. Mikkelson, J. Med. Chem., 1985, 28, 979.
24. A. Monge, I. Aldana, H. Cerecetto and A. Rivero, J. Heterocycl. Chem., 1995, 32, 1429.
25. H. Bundgaard and M. Johansen, Int. J. Pharm., 1982, 10, 165.
26. M. Johansen and H. Bundgaard, J. Pharm. Sci., 1983, 72, 1294.
27. G. P. Moloney, Synthesis and NMR studies of Oxazines and Oxazolidine based compounds, Ph.D. Thesis, Victorian College of Pharmacy Ltd., 1990.
28. A. Buur and H. Bundgaard, Int. J. Pharm., 1984, 18, 325.
29. J. A. Young-Harvey, I. D. Rae and I. H. Pitman, Int. J. Pharm., 1986, 30, 151.
30. H. Bundgaard and M. Johansen, J. Pharm. Sci., 1980, 69, 44.
31. D. Carlstiom, Acta Crystallogr., Sect. B, 1973, 29, 161.
32. M. Mathew and G. J. Palenik, J. Am. Chem. Soc., 1971, 93, 497.
33. Y. Barrans, M. Cotrait and J. Dangoumau, Acta Crystallogr., Sect. B, 1973, 29, 1264.
34. M. Gadret, M. Goursolle, J. M. Leger and J. C. Colleter, Acta Crystallogr., Sect. B, 1975, 31, 2780.
35. M. Gadret, M. Goursolle, J. M. Leger and J. C. Colleter, Acta Crystallogr., Sect. B, 1976, 22, 17.
36. P. N. Patil, D. D. Miller and U. Trendelenburg, Pharmacol. Rev., 1974, 26, 323.
37. J. M. George, L. B. Kier and J. R. Hoyland, Mol. Pharmacol., 1971, 7, 328.
38. A. M. Kuliev, B. R. Gasanov, E. A. Agaeva and S. B. Bilalov, Zh. Prikl. Spektrosk., 1973, 19, 506.
39. N. el Tayar, P. A. Carrupt, H. Van de Waterbeemd and B. Testa, J. Med. Chem., 1988, 31, 2072.
40. M. R. Linschoten, T. Bultsma, A. P. Ijzerman and H. Timmerman, J. Med. Chem., 1986, 29, 278.
41. M. Donne-Op den Kelder, T. Bultsma, H. Timmerman and B. Rademaker, J. Med. Chem., 1988, 31, 1069.
42. J. Dangoumau, Y. Barrans and M. Cotrait, J. Pharmacol., 1973, 4, 5.
43. H. A. Germer, J. Pharm. Pharmacol., 1974, 26, 799.
44. J. P. Beale, Cryst. Struct. Commun., 1972, 1, 67.
45. A. M. Anderson, Acta Chem. Scand., 1975, 29, 871.
46. R. R. Ison, P. Partington and G. C. K. Roberts, Mol. Pharmacol., 1973, 9, 756.
47. J. E. Forrest, R. A. Heacock and T. P. Forrest, J. Pharm. Pharmacol., 1970, 22, 512.
48. A. Balsamo, G. Ceccarelli, P. Crotti, B. Macchia, F. Macchia and P. Tognetti, Eur. J. Med. Chem., 1982, 17, 471.
49. P. S. Portoghese, J. Med. Chem., 1967, 10, 1057.
50. C. Romers, C. Altona, H. R. Buys and E. Havinga, Top. Stereochem., 1969, 4, 39.
51. A. Makriyannis, F. Sullivan and H. G. Mantner, Proc. Natl. Acad. Sci., 1972, 69, 3416.
52. J. Zaagsma, J. Med. Chem., 1979, 22, 441.
53. V. M. Kulkarni, N. Vasanthkumar, A. Saran and G. Govil, Int. J. Quant. Chem. Biol. Symp., 1979, 6, 153.
54. T. L. Nero, W. J. Louis and D. Iakovidis, J. Mol. Struct. (THEOCHEM.), 1993, 285, 251.
55. T. Jen and C. Kaiser, J. Med. Chem., 1977, 20, 693.
56. V. M. Kulkarni and E. Countinho, Int. J. Chem., 1991, 30B, 52.
57. A. Saran, S. Srivastava, V. M. Kulkarni and E. Coutinho, J. Mol. Struct., 1993, 279, 281.
58. R. Clarkson, ACS Symp. Ser., 1976, 27, 1.
59. SYBYL 6.2 molecular modelling package, Tripos Associates, St. Louis, MO, USA 63144.
60. M. Clark, R. D. Cramer and N. Van Opdenbosch, J. Comput. Chem., 1989, 10, 982.
61. J. Gasteiger and M. Marsili, Tetrahedron, 1980, 36, 3219.
62. W. P. Purcell and J. A. Singer, J. Chem. Eng. Data, 1967, 12, 235.
63. M. J. D. Powell, Math. Programm., 1977, 12, 241.
64. M. Lipton and W. C. Still, J. Comput. Chem., 1988, 9, 343.
65. M. Karplus, J. Am. Chem. Soc., 1963, 85, 2870.